Age as a prognostic factor for treatment outcomes in glioblastoma. (P1.175)

Conclusions:In our experience, better outcomes are seen with patients who received more intensive therapy (i.e. chemo-radiation) in both patient groups (< 65 years or ≥65 years of age).Disclosure: Dr. Braun has nothing to disclose. Dr. Mohapatra has nothing to disclose. Dr. Choi has nothing to disclose. Dr. Ahluwalia has received personal compensation for activities with Elkta as an advisory board member, from Monteris Medical as a consultant, and from Merl as a speaker. Dr. Jia has nothing to disclose.

Source: Neurology - April 17, 2017 Category: Neurology Authors: Braun, K., Mohapatra, S., Choi, A., Ahluwalia, M., Jia, X. Tags: Neuro-oncology: Gliomas I Source Type: research